Viewing Study NCT03603951


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
Study NCT ID: NCT03603951
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-01
First Post: 2018-07-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-08-14
Start Date Type: ACTUAL
Primary Completion Date: 2026-02-14
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-08-14
Completion Date Type: ESTIMATED
First Submit Date: 2018-07-10
First Submit QC Date: None
Study First Post Date: 2018-07-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-29
Last Update Post Date: 2024-10-01
Last Update Post Date Type: ACTUAL